Zomedica Corp. Reports FY2025 and Q4 2025 Financial Results

What Happened

• Zomedica Corp. filed a Form 8-K on March 16, 2026 under Item 2.02 (Results of Operations and Financial Condition) to announce the company's financial results for the year and quarter ended December 31, 2025. The company furnished a press release announcing those results as Exhibit 99.1 to the filing.

Key Details

• Filing date: March 16, 2026 (Form 8-K Item 2.02).
• Reporting period: quarter and fiscal year ended December 31, 2025.
• Press release announcing results is included as Exhibit 99.1 to the 8-K.

Why It Matters

• Earnings and year-end financial results are primary drivers of a stock’s near-term performance; this 8-K signals Zomedica has released updated financials for investors to review.
• Retail investors should read the attached press release (Exhibit 99.1) or the company’s detailed filings for revenue, net income/loss, cash position and guidance, since those specifics will determine the business outlook and could affect the ZOMDF share price.